Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$26.12 - $34.07 $1.95 Million - $2.55 Million
74,786 Added 8.35%
969,986 $33 Million
Q1 2024

May 13, 2024

BUY
$26.64 - $40.31 $1.12 Million - $1.7 Million
42,160 Added 4.94%
895,200 $31.5 Million
Q4 2023

Feb 13, 2024

BUY
$19.95 - $31.0 $1.51 Million - $2.35 Million
75,871 Added 9.76%
853,040 $24.6 Million
Q3 2023

Nov 13, 2023

BUY
$21.33 - $59.42 $2.45 Million - $6.84 Million
115,030 Added 17.37%
777,169 $17.8 Million
Q2 2023

Aug 11, 2023

BUY
$34.33 - $62.11 $4.04 Million - $7.31 Million
117,746 Added 21.63%
662,139 $38 Million
Q1 2023

May 15, 2023

BUY
$26.01 - $48.69 $446,279 - $835,423
17,158 Added 3.25%
544,393 $20.5 Million
Q4 2022

Feb 13, 2023

BUY
$24.14 - $30.37 $586,239 - $737,535
24,285 Added 4.83%
527,235 $14.1 Million
Q3 2022

Nov 14, 2022

BUY
$22.23 - $33.37 $598,809 - $898,887
26,937 Added 5.66%
502,950 $14.2 Million
Q2 2022

Aug 12, 2022

BUY
$19.74 - $43.01 $647,945 - $1.41 Million
32,824 Added 7.41%
476,013 $10.3 Million
Q1 2022

May 13, 2022

SELL
$36.25 - $52.02 $20,988 - $30,119
-579 Reduced 0.13%
443,189 $17.8 Million
Q4 2021

Feb 11, 2022

BUY
$43.27 - $65.72 $607,986 - $923,431
14,051 Added 3.27%
443,768 $21 Million
Q3 2021

Nov 12, 2021

BUY
$53.61 - $67.5 $6.27 Million - $7.89 Million
116,888 Added 37.36%
429,717 $24.3 Million
Q2 2021

Aug 13, 2021

BUY
$45.13 - $64.99 $2.96 Million - $4.26 Million
65,571 Added 26.52%
312,829 $18 Million
Q1 2021

May 12, 2021

BUY
$29.77 - $84.85 $1.93 Million - $5.49 Million
64,699 Added 35.44%
247,258 $15.6 Million
Q4 2020

Feb 12, 2021

BUY
$25.66 - $34.55 $579,762 - $780,622
22,594 Added 14.12%
182,559 $6.12 Million
Q3 2020

Nov 13, 2020

BUY
$22.51 - $30.11 $262,691 - $351,383
11,670 Added 7.87%
159,965 $4.37 Million
Q2 2020

Aug 13, 2020

BUY
$12.65 - $29.57 $364,320 - $851,616
28,800 Added 24.1%
148,295 $4.01 Million
Q1 2020

May 14, 2020

BUY
$10.84 - $20.85 $484,179 - $931,286
44,666 Added 59.69%
119,495 $1.75 Million
Q4 2019

Feb 13, 2020

BUY
$13.02 - $19.5 $58,173 - $87,126
4,468 Added 6.35%
74,829 $1.28 Million
Q3 2019

Nov 12, 2019

BUY
$17.46 - $29.05 $1.23 Million - $2.04 Million
70,361 New
70,361 $1.27 Million

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.